Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer

NCT01648010 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma of Urinary Bladder, Invasive

Interventions

DEVICE: TC-3 gel
DEVICE: TC-3 gel mixed with Mitomycin C (MMC)

Sponsor

UroGen Pharma Ltd.